What happens if you have MS and you’ve tested positive for COVID-19? How will the disease affect your disease-modifying therapies and your MS?
Dr. Barry Singer, (@drbarrysinger), a neurologist who directs The MS Center for Innovations in Care in St. Louis, has posed that question to his Twitter followers. Singer learned that some people with MS have been sickened by COVID-19, and the experiences they’re reporting from around the world seem encouraging. Here’s some of what they are saying on Twitter:
‘Flu-like symptoms but doing well’
Giovanna Borriello (@GiovannaBorri19): “In Rome we have one male patient positive to Coronavirus. Treated with Natalizumab (14 infusions done), actually just fever, under observation but not hospitalized. One positive female on DMF hospitalized due to fever and dyspnoea, good recovery in few days.”
AnnekeVdWalt (@anneke_vdw): “Case of person with COVID19 on ocrelizumab in Australia reported today. Mild infection and doing well.”
Elisabeth G. Celius (@CeliusElisabeth): “One patient with infection shortly after w1 in year 2 of Cladribine. Similar symptoms as others otherwise healthy so far.”
NeuroImmunology Club (@NeuroImmunology): “Have one patient with ocrelizumab infected. Doing fine. Flu-like symptoms but doing well.”
Susana Sainz de la Maza (@S_SainzdelaMaza): “I have one 40yo women recently diagnosed with RRMS (had not yet received DMT). High fever, dry cough and shortness of breath due to bilateral neumonia. Grade 4 lymphopenia and elevated C-reactive protein in the blood. Treatment with Kaletra and Dolquine has been initiated.”
Pablo Nieto (@IlNeuroDoktorMS): “I have one. Bilateral neumonia. 68 yo without treatment since 2 years (previously with Rebif). Discharged well last week after 2 weeks of hospitalization. No need ICU.”
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?